Prof. Udi Qimron awarded an ERC POC grant!
The title of the grant is “Harnessing CRISPR-Cas technology for sustainable resistance markers”
Prof. Udi Qimron, PhD, is a member of the Department of Clinical Microbiology and Immunology in the new Gray School of Medical Sciences.
He has authored over 65 scientific articles, some in prestigious journals such as Nature, Science, and Cell. He has already won the prestigious ERC-PoC once, and the ERC grants twice before.
His current research focuses on bacterial defense systems such as CRISPR-Cas, GAPSs, and using these to tackle antibiotic resistance. Bacterial resistance to antibiotics is a major health threat. Rather than producing more antibiotics, which may worsen the problem, Qimron’s lab has taken a unique approach, in which they reverse bacterial resistance to antibiotics.
Qimron’s approach uses the genetic engineering tool, CRISPR-Cas, to eliminate resistance genes from bacteria, and at the same time to enable growth of antibiotic-sensitive bacteria. In the new study, CRISPR adaptation is linked to CRISPR repression to identify antibiotic-sensitizing genes and to harness them for applications in medicine and industry. More information at: https://qimron1lab.wixsite.com/qimronlab
Related Articles
